TY  - GEN
N2  - This book discusses patent legal issues regarding inventions in the field of biotechnology. The scope of a patent is of central concern, and since biotechnology is very different from other technologies, the requirements for disclosure and infringement are in focus. Eligibility issues are touched upon, although from more of an explanatory perspective, since the law is settled in this respect. The material for the analyses includes the European practices under the EPC, those of the United Kingdom, Germany, and the US. The mandated exclusions from patentability under the European patent laws of categories of plant and animal subject matter and certain biological processes are also analysed. Claim interpretation is the common theme. The challenge has been to present a comprehensive basis for grasping the substantive law for the field of biotechnology. The book examines thoroughly the differences between practices, and the consequences of those differences for the possibility of being granted a patent for an invention, and the infringement doctrines' effects for what might be called a patent's 'after-life', i.e. the scope of its protection.
AB  - This book discusses patent legal issues regarding inventions in the field of biotechnology. The scope of a patent is of central concern, and since biotechnology is very different from other technologies, the requirements for disclosure and infringement are in focus. Eligibility issues are touched upon, although from more of an explanatory perspective, since the law is settled in this respect. The material for the analyses includes the European practices under the EPC, those of the United Kingdom, Germany, and the US. The mandated exclusions from patentability under the European patent laws of categories of plant and animal subject matter and certain biological processes are also analysed. Claim interpretation is the common theme. The challenge has been to present a comprehensive basis for grasping the substantive law for the field of biotechnology. The book examines thoroughly the differences between practices, and the consequences of those differences for the possibility of being granted a patent for an invention, and the infringement doctrines' effects for what might be called a patent's 'after-life', i.e. the scope of its protection.
T1  - Biotech patents :equivalence and exclusions under European and U.S. patent law /
AU  - Westerlund, Li,
CN  - K1519.B54
ID  - 13672
KW  - Biotechnology
KW  - Biotechnology industries
KW  - Patents
KW  - Inventions.
KW  - Animal experimentation
KW  - Patent practice
KW  - Trademark infringement
KW  - Patent laws and legislation
KW  - Patent infringement
KW  - UNITED STATES OF AMERICA
KW  - NATIONAL LAW
KW  - EUROPE
KW  - GENETIC ENGINEERING
KW  - BIOTECHNOLOGY
KW  - PATENTS
KW  - Brevets d'invention
SN  - 9041188835
TI  - Biotech patents :equivalence and exclusions under European and U.S. patent law /
ER  -